I agree with Davisite. This looks like repositioning for Telix should cu64 take off. Clearly they think there’s a good chance or they wouldn’t be making this move.
Seems like a smart diversification play for Telix. Reduces risk and gives them exposure to a different part of the value stream.
Definitely a very positive sign for Clarity. I believe the business will be sold off the Cu64 imaging results.
The Cu67 therapy potential can be extrapolated from that especially with good early indications in the therapy trials.
A move on Clarity could happen at anytime.
Is anyone up on the latest developments with Cu64 competitors in this space?
Tlx buys ARTMS - effect on CU-64?, page-12
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CU6 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.39 |
Change
0.240(3.36%) |
Mkt cap ! $2.363B | |||
| Open | High | Low | Value | Volume |
| $7.22 | $7.58 | $7.17 | $4.811M | 648.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 2280 | $7.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.39 | 1092 | 6 |
View Market Depth
| Last trade - 13.42pm 06/11/2024 (20 minute delay) ? |
| CU6 (ASX) Chart |